Arnold D. Essenburg

1.8k citations

34 papers · 1.6k indexed · h-index 20

Endocrinology, Diabetes and Metabolism top 5%
Biochemistry top 5%
Surgery top 5%
- Cholesterol and Lipid Metabolism 18
- Lipoproteins and Cardiovascular Health 14
Cancer Research top 10%
- Cancer, Lipids, and Metabolism 5
Physiology top 10%
Molecular Biology
- Peroxisome Proliferator-Activated Receptors 10
- Steroid Chemistry and Biochemistry 5
- Enzyme function and inhibition 4
Oncology
- Drug Transport and Resistance Mechanisms 4
Pharmacology
- Pharmacogenetics and Drug Metabolism 3

Co-authors: C L Bisgaier Charles L. Bisgaier Katriina Aalto‐Setälä Jan L. Breslow Peter Weinstock Mark R. Emmerling Alex E. Roher Yu‐Min Kuo
Cited by: Endocrinology, Diabetes and Metabolism Biochemistry Surgery
Journals: Journal of Clinical Investigation (2 papers)Biochemical and Biophysical Research Communications (1 paper)Journal of Medicinal Chemistry (11 papers)
Partner nations: United States United Kingdom Russia

In The Last Decade

Arnold D. Essenburg

34 papers receiving 1.4k citations

Peers

Countries citing papers authored by Arnold D. Essenburg

Since Specialization

Citations

This map shows the geographic impact of Arnold D. Essenburg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnold D. Essenburg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnold D. Essenburg more than expected).

Fields of papers citing papers by Arnold D. Essenburg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnold D. Essenburg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnold D. Essenburg. The network helps show where Arnold D. Essenburg may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Arnold D. Essenburg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Arnold D. Essenburg Line = papers co-authored together Arnold D. Essenburg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Expression of the mRNA encoding truncated PPARα does not correlate with hepatic insensitivity to peroxisome proliferators Molecular and Cellular Biochemistry ·Jeffrey C. Hanselman,Marsha V. Vartanian,Benjamin P. Koester,Steven A. Gray,Arnold D. Essenburg,Thomas J. Rea,Charles L. Bisgaier,MichaelE. Pape	2001	19
2	Elevated Low-Density Lipoprotein in Alzheimer's Disease Correlates with Brain Aβ 1–42 Levels Biochemical and Biophysical Research Communications ·Yu‐Min Kuo,Mark R. Emmerling,Charles L. Bisgaier,Arnold D. Essenburg,Heather C. Lampert,Denise A. Drumm,Alex E. Roher	1998	265
3	A novel compound that elevates high density lipoprotein and activates the peroxisome proliferator activated receptor Journal of Lipid Research ·Charles L. Bisgaier,Arnold D. Essenburg,B.C. Barnett,Bruce J. Auerbach,Sabine Haubenwallner,Todd Leff,Andrew D. White,Paul L. Creger,Michael E. Pape,Thomas J. Rea,Roger S. Newton	1998	53
4	Inhibitors of acyl-CoA:cholesterol acyltransferase: novel trisubstituted ureas as hypocholesterolemic agents Bioorganic & Medicinal Chemistry ·Terri S. Purchase,Arnold D. Essenburg,Katherine L. Hamelehle,MaryKay Shaw Hes,Ann Holmes,Brian R. Krause,Richard L. Stanfield,Bharat K. Trivedi	1997	3
5	Attenuation of plasma low density lipoprotein cholesterol by select 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in mice devoid of low density lipoprotein receptors Journal of Lipid Research ·C L Bisgaier,Arnold D. Essenburg,Bruce J. Auerbach,M E Pape,Catherine Sekerke,Andrew Gee,Sabine Wolle,Roger S. Newton	1997	66
6	Large Versus Small Unilamellar Vesicles Mediate Reverse Cholesterol Transport In Vivo Into Two Distinct Hepatic Metabolic Pools Arteriosclerosis Thrombosis and Vascular Biology ·Wendi V. Rodrigueza,Kirstin D. Mazany,Arnold D. Essenburg,Michael E. Pape,Thomas J. Rea,Charles L. Bisgaier,Kevin Jon Williams	1997	41
7	Opposite effects of bezafibrate and gemfibrozil in both normal and hypertriglyceridemic rats Atherosclerosis ·Brian R. Krause,B.C. Barnett,Arnold D. Essenburg,Karen A. Kieft,Bruce J. Auerbach,Richard F. Bousley,Richard L. Stanfield,Roger S. Newton,C L Bisgaier	1996	18
8	Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. Journal of Clinical Investigation ·Peter Weinstock,C L Bisgaier,Katriina Aalto‐Setälä,H. Radner,Rajasekhar Ramakrishnan,Sanja Levak‐Frank,Arnold D. Essenburg,Rudolf Zechner,Jan L. Breslow	1995	259
9	Bioisosterism in drug design: Identification of and structure-activity relationships in a series of glycine anilide ACAT inhibitors Bioorganic & Medicinal Chemistry ·W. Howard Roark,Janak Padia,Gary L. Bolton,C. John Blankley,Arnold D. Essenburg,Richard L. Stanfield,Richard F. Bousley,Brian R. Krause,Bruce D. Roth	1995	3
10	Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior. Journal of Clinical Investigation ·Katriina Aalto‐Setälä,C L Bisgaier,Anthony M.‐H. Ho,Karen A. Kieft,Maret G. Traber,H J Kayden,R Ramakrishnan,A Walsh,Arnold D. Essenburg,Jan L. Breslow	1994	66
11	Inhibitors of Acyl-CoA:Cholesterol Acyltransferase (ACAT). 7. Development of a Series of Substituted N-Phenyl-N'-[(1-phenylcyclopentyl)methyl]ureas with Enhanced Hypocholesterolemic Activity Journal of Medicinal Chemistry ·Bharat K. Trivedi,Terri S. Purchase,Ann Holmes,Corinne E. Augelli‐Szafran,Arnold D. Essenburg,Katherine L. Hamelehle,Richard L. Stanfield,Richard F. Bousley,Brian R. Krause	1994	37
12	Inhibitors of acyl-CoA:cholesterol acyltransferase. 4. A novel series of urea ACAT inhibitors as potential hypocholesterolemic agents Journal of Medicinal Chemistry ·Bharat K. Trivedi,Ann Holmes,Terri L. Stoeber,C. John Blankley,W. Howard Roark,Joseph A. Picard,Mary K. Shaw,Arnold D. Essenburg,Richard L. Stanfield,Brian R. Krause	1993	47
13	Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 2. Modification of fatty acid anilide ACAT inhibitors: bioisosteric replacement of the amide bond Journal of Medicinal Chemistry ·W. Howard Roark,Bruce D. Roth,Ann Holmes,Bharat K. Trivedi,Karen A. Kieft,Arnold D. Essenburg,Brian R. Krause,Richard L. Stanfield	1993	25
14	Substituted N,N′-diphenyl ureas as potent inhibitors of acyl-CoA:Cholesterol acyltransferase (ACAT) Bioorganic & Medicinal Chemistry Letters ·Bharat K. Trivedi,Terri L. Stoeber,Richard L. Stanfield,Arnold D. Essenburg,K. L. HAMELEHLE,Brian R. Krause	1993	4
15	Inhibitors of acyl-CoA:cholesterol acyltransferase. 5. Identification and structure-activity relationships of novel .beta.-keto amides as hypocholesterolemic agents Journal of Medicinal Chemistry ·Corinne E. Augelli‐Szafran,C. John Blankley,Bruce D. Roth,Bharat K. Trivedi,Richard F. Bousley,Arnold D. Essenburg,Katherine L. Hamelehle,Brian R. Krause,Richard L. Stanfield	1993	22
16	Inhibitors of acyl-CoA:cholesterol acyltransferase. 1. Identification and structure-activity relationships of a novel series of fatty acid anilide hypocholesterolemic agents Journal of Medicinal Chemistry ·Bruce D. Roth,C. John Blankley,M. L. HOEFLE,Ann Holmes,W. Howard Roark,Bharat K. Trivedi,Arnold D. Essenburg,Karen A. Kieft,Brian R. Krause,Richard L. Stanfield	1992	57
17	CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors. PubMed ·Harvey Kaplan,Daniel M. Cohen,Arnold D. Essenburg,Terry C. Major,T E Mertz,Michael J. Ryan	1984	17
18	Angiotensin converting enzyme inhibitors: modifications of a tripeptide analog Journal of Medicinal Chemistry ·Robert Meyer,Arnold D. Essenburg,Ronald D. Smith,Harvey Kaplan	1982	19
19	Derivatives of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline: effect of changes at postions 2 and 5 of the hexanoic acid portion Journal of Medicinal Chemistry ·Ronald G. Almquist,Jac Crase,Clive Jennings-White,Robert Meyer,M. L. HOEFLE,Ronald D. Smith,Arnold D. Essenburg,Harvey Kaplan	1982	34
20	Novel synthesis of (S)-1-[5-(benzoylamino)-1,4-dioxo-6-phenylhexyl]-L-proline and analogs: potent angiotensin converting enzyme inhibitors Journal of Medicinal Chemistry ·Robert Meyer,Ernest D. Nicolaides,Francis G. Tinney,Elizabeth A. Lunney,Ann Holmes,M. L. HOEFLE,Ronald D. Smith,Arnold D. Essenburg,Harvey Kaplan,Ronald G. Almquist	1981	33

About Arnold D. Essenburg

Arnold D. Essenburg is a scholar working on Pharmacology, Surgery and Biochemistry, having authored 34 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (18 papers), Lipoproteins and Cardiovascular Health (14 papers), Peroxisome Proliferator-Activated Receptors (10 papers), Cancer, Lipids, and Metabolism (5 papers), Steroid Chemistry and Biochemistry (5 papers), Enzyme function and inhibition (4 papers), Drug Transport and Resistance Mechanisms (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (372 citations), Biochemistry (155 citations) and Surgery (692 citations). Arnold D. Essenburg has collaborated with scholars based in United States, United Kingdom and Russia. Frequent co-authors include C L Bisgaier, Charles L. Bisgaier, Katriina Aalto‐Setälä, Jan L. Breslow, Peter Weinstock, Mark R. Emmerling, Alex E. Roher, Yu‐Min Kuo, Denise A. Drumm and Heather C. Lampert. Their work appears in journals such as Journal of Clinical Investigation, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact